AIDS Vaccine for Asia Network (AVAN): Expanding the Regional Role in Developing HIV Vaccines-Reference-Cited by-同舟云学术

AIDS Vaccine for Asia Network (AVAN): Expanding the Regional Role in Developing HIV Vaccines

Published:2010-09-21 Issue:9 Volume:7 Page:e1000331
ISSN:1549-1676
Container-title:PLoS Medicine
language:en
Short-container-title:PLoS Med

Author:

Kent Stephen J.,Cooper David A.,Chhi Vun Mean,Shao Yiming,Zhang Linqi,Ganguly Nirmal,Bela Budiman,Tamashiro Hiko,Ditangco Rossana,Rerks-Ngarm Supachai,Pitisuttithum Punnee,Van Kinh Nguyen,Bernstein Alan,Osmanov Saladin,

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference38 articles.

1. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.;SP Buchbinder;Lancet,2008

2. HIV vaccine research: the way forward.;AS Fauci;Science,2008

3. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand.;S Rerks-Ngarm;N Engl J Med,2009

4. Medicine. The need for a global HIV vaccine enterprise.;RD Klausner;Science,2003

5. African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent.;P Kaleebu;PLoS Med,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complex challenges of HIV vaccine development require renewed and expanded global commitment;The Lancet;2020-02

2. China CDC’s HIV/AIDS Vaccine Efforts, from Basic Research to Clinical Studies;China CDC Weekly;2020

3. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection;AIDS;2015-03-27

4. Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12;Virologica Sinica;2014-09-28

5. HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo;PLoS ONE;2013-12-31